We see a healthier future. It’s within reach.
The Garvan Institute of Medical Research brings together world-leading researchers and clinicians, collaborating locally and globally, to improve human health. From the individual patient with rare disease, to the many thousands affected by complex, widespread illness, we are pioneering discoveries across the diseases that have the deepest impact on our community.
Founded in 1963, Garvan researchers have made significant breakthroughs for diseases including rare cancers and cancers of the breast, prostate and pancreas, immune deficiency and autoimmunity, COVID-19, diabetes and skeletal disease.
Today, our mission builds on those advances: harnessing all the information encoded in our genome, from DNA to complex organ systems, to better diagnose, treat, predict and prevent disease.
Patients, clinical trials and diverse population cohorts are at the centre of Garvan’s research. We are focused on addressing the unmet needs of those living with disease – where better understanding, new treatments and more effective diagnosis can have the biggest impact for individuals and their family.
Garvan is a founding member of the St Vincent’s Sydney Health Innovation Precinct, Australia’s oldest and most established partnership, located in the heart of Sydney. Our other Cornerstone Partners are St Vincent’s Sydney Public and Private hospitals, and the Clinic, as well as the Victor Chang Cardiac Research Institute. Precinct partners work collaboratively, focusing on medical research and healthcare delivery. Garvan also has strong ties to UNSW Sydney.
Our research is funded through a crucial combination of peer-reviewed government grants and generous philanthropic investment from the community. With the support of our passionate Garvan family, our researchers strive, every day, to create a future where everyone lives longer, healthier lives.